<DOC>
	<DOCNO>NCT02047734</DOCNO>
	<brief_summary>The purpose study determine whether RPC1063 effective treatment relapse multiple sclerosis ( RMS ) .</brief_summary>
	<brief_title>Efficacy Safety Study RPC1063 Relapsing Multiple Sclerosis ( Radiance Study )</brief_title>
	<detailed_description />
	<mesh_term>Sclerosis</mesh_term>
	<mesh_term>Multiple Sclerosis</mesh_term>
	<mesh_term>Interferons</mesh_term>
	<mesh_term>Interferon-beta</mesh_term>
	<mesh_term>Interferon beta-1a</mesh_term>
	<criteria>Multiple sclerosis diagnose revised 2010 McDonald criterion EDSS score 0 5.0 baseline Primary progressive multiple sclerosis</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>May 2016</verification_date>
</DOC>